Literature DB >> 6662997

Cadmium-metallothionein-induced nephropathy: a morphological and autoradiographic study of cadmium distribution, the development of tubular damage and subsequent cell regeneration.

M Murakami, K Cain, M Webb.   

Abstract

A single intravenous dose of 0.8 mg thionein-bound cadmium (Cd) per kg body weight, as the isolated (Cd, Zn)-metallothionein (MT) from rat liver, in rats of the same strain is nephrotoxic, but not lethal. Apical vesiculation in epithelial cells of the renal proximal convoluted tubules is apparent within 1 h of dosing and, by 4 h, is extensive in some of these cells that surround the larger arteries in the cortex. The membranes of these cells appear undamaged. The lesion at first progresses with time; by 24 h, the initially affected cells show extensive necrosis and most proximal convoluted tubular epithelia in other regions of the cortex are hydropically or vacuolarly degenerated. The inner stripe of the outer zone of the medulla and other portions of the nephron (glomerulus, distal tubule and collecting duct), however, appear essentially unaffected. The necrotic changes are maximal at 48 h but, after this time, regeneration begins. By seven days, much of the cell debris has been eliminated and cells of the regenerating or regenerated epithelia are similar in morphology to those of the normal kidney. Electron microscopic autoradiography of kidney sections from rats after administration of 109Cd-metallothionein of high specific activity shows that Cd is not concentrated in endocytotic vesicles, lysosomes, or any other cellular organelle, even at early times after dosing, but is distributed evenly throughout the epithelial cell. Thus, although Cd-MT appears to be taken up endocytotically in the kidney tubules, it appears that liberation of Cd from the metalloprotein must occur very early in the reabsorptive process.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6662997     DOI: 10.1002/jat.2550030504

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  9 in total

1.  The teratogenicity of cadmium-metallothionein in the rat.

Authors:  M Webb; D Holt; N Brown; G C Hard
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

Review 2.  Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy.

Authors:  Mohammad Namdarghanbari; William Wobig; Susan Krezoski; Niloofar M Tabatabai; David H Petering
Journal:  J Biol Inorg Chem       Date:  2011-08-07       Impact factor: 3.358

Review 3.  Molecular and ionic mimicry and the transport of toxic metals.

Authors:  Christy C Bridges; Rudolfs K Zalups
Journal:  Toxicol Appl Pharmacol       Date:  2005-05-01       Impact factor: 4.219

4.  Effect of N-benzyl-D-glucamine dithiocarbamate on renal toxicity induced by cadmium-metallothionein in rats.

Authors:  S Kojima; H Ono; A Furukawa; M Kiyozumi
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

5.  The chronic toxicity of equine cadmium metallothionein in the rat.

Authors:  D Holt; S Sparrow; M Webb
Journal:  Arch Toxicol       Date:  1985-08       Impact factor: 5.153

6.  Effect of pretreatment with cadmium/cysteine or metallothionein on accumulation of cadmium challenged with either complexes.

Authors:  K T Suzuki; T Takahara; H Watanabe; M Nishikawa; M Yamamura; M Murakami
Journal:  Arch Toxicol       Date:  1986-04       Impact factor: 5.153

7.  Acute renal dysfunction by cadmium injected with cysteine in relation to renal critical concentration of cadmium.

Authors:  T Maitani; A Watahiki; K T Suzuki
Journal:  Arch Toxicol       Date:  1986-02       Impact factor: 5.153

8.  An electrophysiological freeze fracture assessment of cadmium nephrotoxicity in vitro.

Authors:  D J Hazen-Martin; D A Sens; J G Blackburn; M C Flath; M A Sens
Journal:  In Vitro Cell Dev Biol       Date:  1989-09

Review 9.  Chronic Kidney Disease and Exposure to Nephrotoxic Metals.

Authors:  Sarah E Orr; Christy C Bridges
Journal:  Int J Mol Sci       Date:  2017-05-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.